Meridian Bioscience Announces Closing of Transaction to Acquire Business of GenePOC
June 03 2019 - 4:28PM
Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic
testing solutions and life science raw materials, today announced
it has completed its previously announced acquisition of the
business of GenePOC Inc., a Quebec City, Quebec, Canada based
provider of molecular diagnostic instruments and assays.
About Meridian Bioscience, Inc.
Meridian is a fully integrated life science company that
develops, manufactures, markets and distributes a broad range of
innovative diagnostic products. We are dedicated to developing and
delivering better solutions that give answers with speed, accuracy
and simplicity that are redefining the possibilities of life from
discovery to diagnosis. Through discovery and development, we
provide critical life science raw materials used in immunological
and molecular tests for human, animal, plant, and environmental
applications. Through diagnosis, we provide diagnostic solutions in
areas including gastrointestinal and upper respiratory infections
and blood lead level testing. We build relationships and provide
solutions to hospitals, reference laboratories, research centers,
veterinary testing centers, physician offices, diagnostics
manufacturers, and biotech companies in more than 70 countries
around the world.
Meridian’s shares are traded on the NASDAQ Global Select Market,
symbol VIVO. Meridian’s website address is
www.meridianbioscience.com.
Contact:Jack KennyChief Executive
OfficerMeridian Bioscience, Inc.Phone: 513.271.3700Email:
mbi@meridianbioscience.com
Meridian Bioscience (NASDAQ:VIVO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Meridian Bioscience (NASDAQ:VIVO)
Historical Stock Chart
From Apr 2023 to Apr 2024